Vyro Bio

0 followers


Vyro develops oncolytic viruses designed to target CNS tumors, based on pioneering research on the oncolytic properties of the Zika Virus.

Industries

Headquarters

Stage

Employees

Links

Org chart

Hugo Cabrera
CEO & Co-Founder

Hugo Cabrera

Collapse
Carolini Kaid
Chief Executive Officer
Flávia Santoro
Marketing Assistant
Gabriela Minamoto
Administrative Assistant
Fabiane Honório
Laboratory Technician